We are live on
!
Find out more
SRL
Scientech Research LLC Portfolio holdings
AUM
$120M
1-Year Est. Return
73.62%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+73.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$93.6M
Cap. Flow
% of AUM
93.16%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
310
New
310
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$2.08M |
| 2 |
Palo Alto Networks
PANW
|
+$1.63M |
| 3 |
United Therapeutics
UTHR
|
+$1.47M |
| 4 |
Crown Castle
CCI
|
+$1.42M |
| 5 |
Hershey
HSY
|
+$1.29M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.15% |
| 2 | Healthcare | 13.32% |
| 3 | Consumer Discretionary | 12.29% |
| 4 | Industrials | 11.93% |
| 5 | Financials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
276
DELISTED
bluebird bio
BLUE
| $68.8K | 0.07% |
+2,492
| New | +$152K |
|
277
Cogent Biosciences
COGT
$6.62B
| $68.6K | 0.07% |
+11,649
| New | +$89.3K |
|
278
Banco Bradesco
BBD
$37.8B
| $65K | 0.06% |
+18,574
| New | +$58.3K |
|
|
INFN
279
DELISTED
Infinera Corporation Common Stock
INFN
| $56.1K | 0.06% |
+11,815
| New | +$46.5K |
|
280
Lloyds Banking Group
LYG
$85.8B
| $51.8K | 0.05% |
+21,739
| New | +$46.6K |
|
281
Ambev
ABEV
$47.4B
| $48.5K | 0.05% |
+17,293
| New | +$46.7K |
|
282
ChargePoint
CHPT
$146M
| $43.3K | 0.04% |
+926
| New | +$51.8K |
|
283
Gaotu Techedu
GOTU
$408M
| $37.5K | 0.04% |
+10,327
| New | +$29K |
|
284
Scilex Holding
SCLX
$56M
| $36.3K | 0.04% |
+511
| New | +$26.5K |
|
285
PMV Pharmaceuticals
PMVP
$69.3M
| $35.1K | 0.03% |
+11,322
| New | +$30K |
|
|
MLGO
286
MicroAlgo
MLGO
$46.1M
| $35K | 0.03% |
+6
| New | +$107K |
|
287
Angi Inc
ANGI
$251M
| $34.1K | 0.03% |
+1,371
| New | +$28K |
|
|
MREO
288
Mereo BioPharma
MREO
$49.6M
| $32.2K | 0.03% |
+13,955
| New | +$26.7K |
|
289
Blend Labs
BLND
$433M
| $31.8K | 0.03% |
+12,466
| New | +$18.8K |
|
290
Bakkt Inc
BKKT
$354M
| $30.5K | 0.03% |
+548
| New | +$19K |
|
291
Better Home & Finance Holding
BETR
$436M
| $30.1K | 0.03% |
+749
| New | +$18K |
|
292
Ginkgo Bioworks
DNA
$502M
| $24.8K | 0.02% |
+369
| New | +$22.6K |
|
293
Personalis
PSNL
$1.41B
| $23.9K | 0.02% |
+11,455
| New | +$14.8K |
|
|
ZH
294
Zhihu
ZH
$273M
| $20.9K | 0.02% |
+3,723
| New | +$22.2K |
|
|
NSTG
295
DELISTED
NanoString Technologies, Inc.
NSTG
| $20.8K | 0.02% |
+27,549
| New | +$29.1K |
|
296
Seer Inc
SEER
$114M
| $19.5K | 0.02% |
+10,010
| New | +$17.8K |
|
297
Passage Bio
PASG
$15.7M
| $19K | 0.02% |
+943
| New | +$13K |
|
|
NVTA
298
DELISTED
Invitae Corporation
NVTA
| $17.5K | 0.02% |
+27,857
| New | +$16.7K |
|
299
Nektar Therapeutics
NKTR
$2.22B
| $17.1K | 0.02% |
+2,015
| New | +$15.3K |
|
|
TVRD
300
Tvardi Therapeutics
TVRD
$28.3M
| $16.2K | 0.02% |
+609
| New | +$25.2K |
|
Similar funds
TWM
SA
WAG
ACM
DG
AA
CM
B
Scientech Research LLC's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for Scientech Research LLC, which disclosed 310 positions worth $100M. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Synopsys: 4,061 shares worth $2.09M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, followed by Healthcare and Consumer Discretionary.
- Scientech Research LLC's largest Q4 2023 buy was Synopsys: 4,061 shares worth $2.09M.
- Scientech Research LLC's ten largest holdings make up 14% of its $100M portfolio in Q4 2023.
- Scientech Research LLC disclosed 310 positions in Q4 2023, its first 13F filing on record.
Based on Scientech Research LLC's 13F filing for Q4 2023, filed 14 Feb 2024.